Washington Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-54
| Closed | -$3.91K | – | 401 |
|
2025
Q1 | $3.91K | Sell |
54
-19
| -26% | -$1.38K | ﹤0.01% | 676 |
|
2024
Q4 | $5.41K | Sell |
73
-502
| -87% | -$37.2K | ﹤0.01% | 726 |
|
2024
Q3 | $37.9K | Sell |
575
-182
| -24% | -$12K | ﹤0.01% | 493 |
|
2024
Q2 | $69.9K | Buy |
757
+18
| +2% | +$1.66K | ﹤0.01% | 397 |
|
2024
Q1 | $70.6K | Buy |
739
+11
| +2% | +$1.05K | ﹤0.01% | 404 |
|
2023
Q4 | $55.5K | Sell |
728
-2
| -0.3% | -$153 | ﹤0.01% | 414 |
|
2023
Q3 | $50.6K | Hold |
730
| – | – | ﹤0.01% | 389 |
|
2023
Q2 | $68.9K | Buy |
730
+26
| +4% | +$2.45K | ﹤0.01% | 373 |
|
2023
Q1 | $58.2K | Buy |
704
+6
| +0.9% | +$496 | ﹤0.01% | 390 |
|
2022
Q4 | $52.1K | Buy |
698
+500
| +253% | +$37.3K | ﹤0.01% | 398 |
|
2022
Q3 | $16K | Sell |
198
-33
| -14% | -$2.67K | ﹤0.01% | 578 |
|
2022
Q2 | $22K | Sell |
231
-264
| -53% | -$25.1K | ﹤0.01% | 534 |
|
2022
Q1 | $59K | Sell |
495
-3
| -0.6% | -$358 | ﹤0.01% | 407 |
|
2021
Q4 | $64K | Sell |
498
-67,966
| -99% | -$8.73M | ﹤0.01% | 399 |
|
2021
Q3 | $7.75M | Buy |
68,464
+26
| +0% | +$2.94K | 0.22% | 113 |
|
2021
Q2 | $7.09M | Buy |
68,438
+267
| +0.4% | +$27.7K | 0.2% | 112 |
|
2021
Q1 | $5.7M | Sell |
68,171
-40
| -0.1% | -$3.35K | 0.18% | 118 |
|
2020
Q4 | $6.22M | Buy |
68,211
+2,321
| +4% | +$212K | 0.2% | 111 |
|
2020
Q3 | $5.26M | Sell |
65,890
-288
| -0.4% | -$23K | 0.19% | 109 |
|
2020
Q2 | $4.57M | Buy |
66,178
+655
| +1% | +$45.3K | 0.19% | 112 |
|
2020
Q1 | $4.12M | Buy |
65,523
+17,277
| +36% | +$1.09M | 0.2% | 111 |
|
2019
Q4 | $3.75M | Buy |
+48,246
| New | +$3.75M | 0.15% | 123 |
|
2018
Q3 | – | Sell |
-1,872
| Closed | -$91K | – | 421 |
|
2018
Q2 | $91K | Buy |
+1,872
| New | +$91K | ﹤0.01% | 332 |
|